← 產業報告目錄
AI in Pharmacovigilance Market Size, Share & Trends Analysis Distribution by Component (Software, Services), Deployment (On-premises, Cloud-based), End User (Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Others) and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-03-11頁數 180報告編號 INSIGHTACE-c06bde8004
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide AI in Pharmacovigilance Market is poised to register a CAGR of 14.6%.
At its core, AI in Pharmacovigilance pertains to the use of machine learning, natural language processing, and other ai technologies to improve the monitoring, detection, ev. Stakeholders across the technology and communications landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI in Pharmacovigilance Market Snapshot
Chapter 4. Global AI in Pharmacovigilance Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI in Pharmacovigilance Market Industry Trends
4.10. Global AI in Pharmacovigilance Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI in Pharmacovigilance Market Segmentation 1: By Component, Estimates & Trend Analysis
5.1. Market Share by Component, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Component:
5.2.1. Software
5.2.2. Services
Chapter 6. AI in Pharmacovigilance Market Segmentation 2: By Deployment, Estimates & Trend Analysis
6.1. Market Share by Deployment, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Deployment:
6.2.1. On-premises
6.2.2. Cloud-based
Chapter 7. AI in Pharmacovigilance Market Segmentation 3: By End-user, Estimates & Trend Analysis
7.1. Market Share by End-user, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
7.2.1. Pharmaceutical and Biotech Companies
7.2.2. Contract Research Organizations (CROs)
7.2.3. Others
Chapter 8. AI in Pharmacovigilance Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global AI in Pharmacovigilance Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.2.3. North America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.2.4. North America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.3. Europe
8.3.1. Europe AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.3.3. Europe AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.3.4. Europe AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.4.3. Asia Pacific AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.4.4. Asia Pacific AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.5. Latin America
8.5.1. Latin America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.5.3. Latin America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.5.4. Latin America AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.6.3. Middle East & Africa AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.6.4. Middle East & Africa AI in Pharmacovigilance Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. WNS
9.2.1.1. Business Overview
9.2.1.2. Key Component/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Accenture Plc
9.2.3. IQVIA Inc
9.2.4. Oracle
9.2.5. PAREXEL International Corporation
9.2.6. Cognizant
9.2.7. Aris Global
9.2.8. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們